TEMOZOLOMIDE 250 mg Pill - white capsule/oblong
Pill with imprint TEMOZOLOMIDE 250 mg is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Sandoz Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMOZOLOMIDE 250 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 250 mg
- Strength
- 250 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-2696
- Inactive Ingredients
-
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
water,
ammonia,
potassium hydroxide,
ferric oxide red,
titanium dioxide,
sodium lauryl sulfate,
ferric oxide brown,
ferrosoferric oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 250 mg"
Featured
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Reviews & ratings
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.